The South Gibson Star-Times serves the towns of Haubstadt, Owensville and Fort Branch.
Issue link: https://www.ifoldsflip.com/i/1490101
Tuesday, Januar y 17, 2023 South Gibson Star-Times B-1 Submit news items: Call: 812-753-3553 Email: news@sgstartimes.com NEWS New imaging agent to help find lung cancer By Brittany Steff Purdue News Service bsteff@purdue.edu Surger y, especially surger y to remove cancerous tumors, relies on a range of tools and techniques as well as on the skill of the surgeon. Now, new imaging agent Cytalux will make surger y to remove lung cancer tumors a little more exact. The inside of the human body famously looks nothing like an anatomy textbook, lack- ing the bright color coding to differentiate between tissues and organs. Based on foun- dational intellectual property developed at Purdue Universi- ty and released by On Target Laboratories, Cytalux helps make tumors more easily and immediately identifiable by il- luminating them and making them glow against healthy, noncancerous tissue like bea- cons against a night sky. Philip Low (rhymes with "now"), Purdue's Presidential Scholar for Drug Discover y and the Ralph C. Corley Distin- guished Professor of Chemis- tr y in the College of Science, is an inventor of the drug. "Non-small cell lung cancer is one of the deadliest can- cers," Low said. "The only ab- solute cure for lung cancer is to surgically remove all of the malignant tissue out of the pa- tient. If it has metastasized, it's generally lethal." Lung cancer is the second most commonly diagnosed cancer in the world and ac- counts for more than a quarter of all cancer deaths in the U.S. ever y year. When a patient is diagnosed with non-small cell lung cancer, the prognosis is often bleak: Only 7% have a chance of living another five years. The importance of remov- ing all the malignant tissue, the difficulty in distinguishing cancerous tissue from healthy tissue and the widespread nature of this type of lung cancer make the use of Cyta- lux in lung cancer surger y a welcome development. Low, a chemist by trade, attacks these issues using his expertise in chemical reactions. Cytalux exploits the unique chemistr y of cancer cells to light up the tumors. Cancer cells divide rapidly, much faster than normal cells. To do this, they need folate, a type of B vitamin — and lots of it. The genius of Cytalux is that, after being administered intravenously to a patient be- fore surger y, it tags that folate compound with a fluorescent dye. The cancer cells grab for the folate but end up flagged with the fluorescent dye, too. During surger y, these cells then fluoresce under near-in- frared light. Low explains fur- ther how the drug works in this YouTube video. The newly authorized use of Cytalux, which was initially developed to target ovarian cancer, has the potential to improve the outcomes of thou- sands of patients, helping sur- geons to visualize other wise undetected cancer tissue in 24% of lung cancer patients in a clinical trial. "Cancer cells have an enor- mous appetite for this vitamin, and we have exploited their greed for folic acid by attach- ing a fluorescent dye to it," Low said. "The drug not only allows the surgeon to see the cancer but may also help sur- geons avoid removing tissue. Being able to avoid cutting healthy tissue can be as im- portant as removing unhealthy tissues." Low and his team continue to develop imaging agents to make cancer tumors easier to detect and remove. He hopes that in the future all solid-tu- mor cancers will have a target- ed fluorescent marker to light the way for surgeons. "We're leading the way in this effort," Low said. "We are pioneers. We were not only the first tumor-targeted fluores- cent dye to be approved by the FDA, but we developed a sec- ond one close on its heels. We are also working on other tu- mor-targeted fluorescent dyes to target many other types of cancer." Low conducts his research as part of the Purdue Center By Brittany Steff Purdue News Service bsteff@purdue.edu The standard image of Antarctica is vast, fea- tureless sheets of ice and blowing blizzards. But soaring rocky mountains with deep valleys cut like a knife into the continent of Antarctica, evoking the lavish landscapes of the American Southwest's Monument Valley. Here, ancient rocks reach for the cold blue sky, and here is where Marissa Tremblay, assistant professor of earth, atmospheric, and planetar y sciences in Purdue University's College of Science, led her team of science experts – all of whom hap- pen to be women. Their goal in traveling to what is essentially the ends of the Earth was to look far into the past of Antarctica's climate histor y. Research- ers have long examined ice cores to under- stand the climate histor y of Antarctica, but that research can go only as far back as the oldest ice they can access. To dig deeper into the past – to learn more about some of Earth's warm periods, when Antarctica lost much of its ice – scientists need to look to the rocks. Tremblay is a noble gas geochemist who has pioneered a new way of looking at rocks and analyzing what temperatures they have expe- rienced using tiny amounts of noble gas inside the rock. She has already used this technique to study climate histor y in the European Alps and other places, and she hopes that Antarc- tic rocks will tell an even older stor y, taking a deeper dive into ancient histor y. "One of the most exciting things about this trip – other than the trip itself – is the possibil- ity of revealing how warm the Antarctic conti- nent was before our oldest ice core records," Tremblay said. "Understanding what Antarcti- ca, and the Earth, looked like in the past can help us peer into and predict potential futures." Tremblay and her team trekked into Antarc- tica's remote McMurdo Dr y Valleys to sample rocks and record the weather, temperature and atmospheric conditions at a number of sites. The rocks here, at one of the driest and most remote places on Earth, are devoid of ice. They have been exposed to the atmosphere, and al- most nothing else, for millions of years. The team included Tremblay's doctoral student Emily Apel, who is focusing on this research as part of her dissertation; geologist Jennifer Lamp of Columbia University's Lam- ont-Doherty Earth Obser vator y, who oversaw the weather and temperature instruments; and geochemist Marie Bergelin of the Berkeley Geochronology Center, who sampled rocks and helped install the instruments. The rock samples they collected are being sent in cold storage on a ship to Tremblay's lab at Purdue. Once they arrive, she will use her unique expertise to analyze the samples and conduct more detailed research alongside Dar- r yl Granger, Purdue geologist and professor of earth, atmospheric, and planetar y sciences. "Three to 3.3 million years ago, carbon di- oxide concentrations in the atmosphere were similar to today, and sea levels were 50 feet or more higher – about the height of a five-stor y building!" Tremblay said. "This required the entire Greenland ice sheet to have melted, as well as a significant portion of the Antarctic ice sheets. Today, ice sheets cover most of Antarctica, but they are vulnerable to climate change. But just how vulnerable are they, and how much will they contribute to sea level rise as our planet continues to warm? Those are the questions we're hoping to answer with this new research." INTO THE UNKNOWN Geochemist leads an all-woman team onto the ice in Antarctica Tremblay and her team trekked into antarctica's remote dry Valleys to take rock samples and record the weather, tem- perature and atmospheric conditions at a number of sites. The rock samples they collected are being shipped to Tremblay's lab at Purdue, in cold storage on a ship. Once arrived, she will run the chemical analyses and more detailed research. Marissa Tremblay, associate professor of earth, atmospheric, and planetary sciences at Purdue university and an expert in geochronology, lead an all-women team of researchers into the wilds of antarctica to research the climate history of the continent — and the planet. See CanCeR on page 3

